References
1
Zeelen F.
In Cytotoxic Agents in Hormone Responsive Tumors
Raus J.
Martins H.
LeClerq G.
Academic Press;
New York:
1980.
p.39
2
Bucourt R.
Vignau M.
Torelli V.
J. Biol. Chem.
1978,
253:
8221
3
Mühlenbruch B.
Kirmeier F.
Roth HJ.
Arch. Pharm. (Weinheim, Ger.)
1986,
319:
177
4
Belanger A.
Philibert D.
Teutsch G.
Steroids
1981,
37:
361
5
Reiner GC.
Katzenellenbogen BS.
Bindal RD.
Katzenellenbogen JA.
Cancer Res.
1984,
44:
2302
6
Fevig TL.
Mao MK.
Katzenellenbogen JA.
Steroids
1988,
51:
471
7
Omar AM.
Aboulwafa OM.
J. Heterocycl. Chem.
1984,
21:
1419
8
Boivin RP.
Luu-The V.
Lachance R.
Labrie F.
Poirier D.
J. Med. Chem.
2000,
43:
4465
9
Peters RH.
Crowe DF.
Avery MA.
Chong WK.
Tanabe M.
J. Med. Chem.
1989,
32:
1642
10
Brown DW.
Mahon MF.
Ninan A.
Sainsbury M.
J. Chem. Soc., Perkin Trans. 1
1997,
2329
11
Ibrahim EA.
Omar AM.
Habib NS.
Aboulwafa OM.
Bourdais J.
J. Heterocycl. Chem.
1982,
19:
761
12
Omar AM.
Aboulwafa OM.
J. Pharm. Sci.
1982,
71:
983
13
Hajnal A.
Wölfling J.
Schneider G.
Collect. Czech. Chem. Commun.
1998,
63:
1613
14
Boyer JH.
Canter FC.
Hamer J.
Puteny RK.
J. Am. Chem. Soc.
1956,
78:
325
15
Badiang JG.
Aubé J.
J. Org. Chem.
1996,
61:
2484
16
Aubé J.
Gracias V.
Milligan GL.
J. Am. Chem. Soc.
1995,
117:
8047
17
General Experimental Procedure: A solution of 1 mmol of 3-methoxy-16β-azidomethyl-1,3,5(10)-trien-estra-17β-ol (preparation
[13]
) and 1.1 mmol of the corresponding aldehyde in 3 mL of CH2Cl2 was cooled to 0 °C, followed by the dropwise addition of 2 mmol of acidic catalyst in 2 mL of CH2Cl2. The addition of the catalyst was accompanied by N2 evolution. The reaction was allowed to warm to r.t. and the solution was stirred for 60 min and monitored by TLC [tert-butyl methyl ether:light petroleum (30:70)]. After the complete conversion of the 3-methoxy-16β-azidomethyl-1,3,5(10)-trien-estra-17β-ol, sat. NaHCO3 solution was added to the reaction mixture, which was stirred until bubbling ceased. After extraction with CH2Cl2, the combined organic phase was washed with brine, dried with anhydrous Na2SO4, and then evaporated. The crude products were chromatographed on silica gel with tert-butyl methyl ether:light petroleum (20:80).
18 The reactions with several acids gave the following results. Acid catalyst, yield of 6a: H3[P(W3O10)4] (2 equiv), 17%; H2SO4 (2 equiv), 52%; SnCl4 (2 equiv), 60%; BF3·OEt2 (2 equiv), 82%.
19 Characteristic data for compound 5a: yield 91%, mp 197-199 °C, [α]D
20 +124.
20
Gadre SR.
Suresh CH.
J. Org. Chem.
1997,
62:
2625
21
Representative Examples:
6b: 1H NMR (500 MHz, CDCl3): δ = 0.85 (s, 3 H, 18-H3), 1.30-2.39 (overlapping m, 12 H, 7-H2, 8-H, 9-H, 11-H2, 12-H2, 14-H, 15-H2, 16-H), 2.88 (m, 2 H, 6-H2), 3.09 (dd, 1 H, J = 15.3 Hz, 10.5 Hz, 16a-Hax), 3.78 (s, 3 H, 3-OCH3), 3.97 (dd, 1 H, J = 15.3 Hz, 7.6 Hz, 16a-Heq), 4.15 (d, 1 H, J = 9.8 Hz, 17α-H), 6.64 (d, 1 H, J = 2.4 Hz, 4-H), 6.72 (dd, 1 H, J = 8.6 Hz, 2.4 Hz, 2-H), 7.22 (d, 1 H, J = 8.6 Hz, 1-H), [8.11 (d, 2 H, J = 8.8 Hz) and 8.23 (d, 2 H, J = 8.8 Hz)]:[2′-H, 6′-H, 3′-H, 5′-H]. 13C NMR (125 MHz, CDCl3): δ = 13.4 (C-18), [26.2, 27.5, 29.7, 31.2, 37.6]:[C-6, C-7, C-11, C-12, C-15], 31.0 (C-16), 38.1 (C-8), 44.0 (C-9), 44.6 (C-13), 48.0 (C-14), 49.2 (C-16a), 55.2 (3-OCH3), 85.7 (C-17), 111.6 (C-2), 113.8 (C-4), 123.2 (2C, C-3′, C-5’), 126.3 (C-1), 128.0 (2C, C-2′, C-6′), 132.1 (C-10), 137.7 (C-5), 139.8 (C-1′), 149.0 (C-4′), 155.5 [C(N,O)], 157.5 (C-3). MS: m/z = 446 [M+]. C27H30N2O4.
6c: 1H NMR (500 MHz, CDCl3): δ = 0.85 (s, 3 H, 18-H3), 1.30-2.41 (overlapping m, 12 H, 7-H2, 8-H, 9-H, 11-H2, 12-H2, 14-H, 15-H2, 16-H), 2.88 (m, 2 H, 6-H2), 3.09 (dd, 1 H, J = 15.2 Hz, J = 10.6 Hz, 16a-Hax), 3.78 (s, 3 H, 3-OCH3), 3.96 (dd, 1 H, J = 15.2 Hz, J = 7.4 Hz, 16a-Heq), 4.16 (d, 1 H, J = 9.8 Hz, 17α-H), 6.64 (d, 1 H, J = 2.7 Hz, 4-H), 6.72 (dd, 1 H, J = 8.6 Hz, 2.7 Hz, 2-H), 7.22 (d, 1 H, J = 8.6 Hz, 1-H), 7.56 (t, 1 H, J = 8.0 Hz, 5′-H), [8.27 (d, 1 H, J = 8.0 Hz), 8.31 (d, 1 H, J = 8.0 Hz)]:[4′-H, 6′-H], 8.79 (s, 1 H, 2′-H). 13C NMR (125 MHz, CDCl3): δ = 13.3 (C-18), [26.2, 27.5, 29.7, 31.2, 37.6]:[C-6, C-7, C-11, C-12, C-15], 31.0 (C-16), 38.1 (C-8), 44.0 (C-9), 44.6 (C-13), 47.9 (C-14), 49.0 (C-16a), 55.2 (3-OCH3), 85.7 (C-17), 111.6 (C-2), 113.8 (C-4), 122.2 (C-2′), 124.9 (C-4′), 126.3 (C-1), 129.0 (C-5′), 132.2 (C-10), 133.0 (C-6′), 135.9 (C-1′), 137.7 (C-5), 148.3 (C-3′), 155.2 [C(N,O)], 157.6 (C-3). MS: m/z = 446 [M+]. C27H30N2O4.
6d: 1H NMR (500 MHz, CDCl3): δ = 0.84 (s, 3 H, 18-H3), 1.27-2.49 (overlapping m, 12 H, 7-H2, 8-H, 9-H, 11-H2, 12-H2, 14-H, 15-H2, 16-H), 2.87 (m, 2 H, 6-H2), 3.02 (dd, 1 H, J = 14.5 Hz, 11.2 Hz, 16a-Hax), 3.77 (s, 3 H, 3-OCH3), 3.92 (dd, 1 H, J = 14.5 Hz, 7.3 Hz, 16a-Heq), 3.99 (d, 1 H, J = 8.8 Hz, 17α-H), 6.63 (d, 1 H, J = 2.6 Hz, 4-H), 6.71 (dd, 1 H, J = 8.6 Hz, 2.6 Hz, 2-H), 7.19 (d, 1 H, J = 8.6 Hz, 1-H), 7.53 (t, 1 H, J = 7.6 Hz, 4′-H), 7.60 (t, 1 H, J = 7.6 Hz, 5′-H), [7.78 (d, 1 H, J = 7.6 Hz), 7.81 (d, 1 H, J = 7.6 Hz)]:[3′-H, 6′-H]. 13C NMR (125 MHz, CDCl3): δ = 13.4 (C-18), [26.1, 27.5, 29.7, 30.7, 37.3]:[C-6, C-7, C-11, C-12, C-15], 30.7 (C-16), 38.1 (C-8), 44.0 (C-9), 44.4 (C-13), 47.8 (C-14), 48.9 (C-16a), 55.2 (3-OCH3), 87.3 (C-17), 111.5 (C-2), 113.8 (C-4), 123.7 (C-3′), 126.3 (C-1), 129.9 (C-1′), 130.3 (C-6′), 131.0 (C-4′), 132.2 (C-10), 132.3 (C-5′), 137.7 (2C, C-5, C-2′), 157.0 [C(N,O)], 157.5 (C-3). MS: m/z = 446 [M+]. C27H30N2O4.
8c: 1H NMR (500 MHz, CDCl3): δ = 0.90 (s, 3 H, 18-H3), 1.26-2.86 (overlapping m, 14 H, 6-H2, 7-H2, 8-H, 9-H, 11-H2, 12-H2, 14-H, 15-H2, 16-H), 2.76 (m, 2 H,), 3.67 (m, 2 H, 16a-H2), 3.77 (s, 3 H, 3-OCH3), 4.30 (d, 1 H, J = 5.5 Hz, 17β-H), 6.59 (d, 1 H, J = 2.7 Hz, 4-H), 6.70 (dd, 1 H, J = 8.6 Hz, 2.7 Hz, 2-H), 7.18 (d, 1 H, J = 8.6 Hz, 1-H), 8.14 (d, 2 H, J = 8.9 Hz, 2′-H, 6′-H), 8.23 (d, 2 H, J = 8.9 Hz, 3′-H, 5′-H). 13C NMR (125 MHz, CDCl3): δ = 17.1 (C-18), [26.0, 27.9, 29.8, 31.0, 31.2]:[C-6, C-7, C-11, C-12, C-15], [32.7, 39.0, 43.6]:[C-8, C-9, C-16], 45.9 (C-16a), 47.5 (C-13), 49.0 (C-14), 55.2 (3-OCH3), 85.6 (C-17), 111.5 (C-2), 113.8 (C-4), 123.3 (2C, C-3′, C-5′), 126.2 (C-1), 127.9 (2C, C-2′, C-6′), 132.2 (C-10), 137.8 (C-5), 139.8 (C-1′), 149.1 (C-4′), 155.5 [C(N,O)], 157.5 (C-3). MS: m/z = 446 [M+]. C27H30N2O4.
9c: 1H NMR (500 MHz, CDCl3): δ = 0.84 (s, 3 H, 18-H3), 1.33-2.41 (overlapping m, 11 H, 7-H2, 8-H, 9-H, 11-H2, 12-H2, 14-H, 15-H2), 2.68 (m, 1 H, 16-H), 2.84 (m, 2 H, 6-H2), 3.76 (s, 3 H, 3-OCH3), 3.95 (d, 1 H, J = 5.1 Hz, 17β-H), 5.57 [t, 1 H, J = 2.9 Hz, CH(N,O)], 6.62 (d, 1 H, J = 2.6 Hz, 4-H), 6.71 (dd, 1 H, J = 8.6 Hz, 2.7 Hz, 2-H), 7.20 (d, 1 H, J = 8.6 Hz, 1-H), 7.79 (d, 2 H, J = 8.5 Hz, 2′-H, 6′-H), 8.03 (t, 1 H, J = 2.7 Hz, 16a-H), 8.23 (d, 2 H, J = 8.5 Hz, 3′-H, 5′-H).
13C NMR (125 MHz, CDCl3): δ = 16.4 (C-18), [26.0, 28.0, 28.9, 29.8, 30.7]:[C-6, C-7, C-11, C-12, C-15], [38.1, 38.8, 43.4, 47.1]:[C-8, C-9, C-14, C-16], 46.6 (C-13), 55.2 (3-OCH3), [82.5, 85.2]:[CH(N,O), C-17], 111.6 (C-2), 113.8 (C-4), 123.4 (2C, C-3′, C-5′), 126.3 (C-1), 127.6 (2C, C-2′, C-6′), 132.4 (C-10), 137.8 (C-5), 147.5 (C-4′), 147.9 (C-1′), 157.5 (C-3), 165.1 (C-16a). MS: m/z = 446 [M+]. C27H30N2O4.
The compounds gave correct elemental analyses.